Skip to content

Pentostatin

Nipent (pentostatin) is a small molecule pharmaceutical. Pentostatin was first approved as Nipent on 1991-10-11. It is used to treat hairy cell leukemia in the USA. The pharmaceutical is active against adenosine deaminase. In addition, it is known to target adenosine deaminase.
Trade Name Nipent
Common Name Pentostatin
Indication hairy cell leukemia
Drug Class Enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors)
Pentostatin
Get full access now